Answer:
Explanation:
This is because, during lytic cycle,
During the lytic cycle, genome willing f the virus always undergo replication and transcription and the enzymes then degraded the bacteria chromosomes which has been coded by the viral genome to produce deoxyribonucleotides that acts as monomers to in order to produce more viral DNA so that virus will be replicated the more.
The virus find it's way into the the bacteria, then take over the whole macromolecular production and degrade components that are in existence in bacteria so as to get new materials to replicate alot of copies of itself.
Answer:
c. False
This statement is incorrect because the DNA of bacteria is circular without histones.
Explanation:
a. True
Some archaea have very specific lipids in their membrane. Differently of the bacterias that have usual lipids in their membranes.
b. True
Archaebacteria do not have peptidoglycans in their cell wall
d. True
Methanogenic archaeobacteria are those that use carbon dioxide and hydrogen to produce methane. They are found in the digestive system of ruminants, sewers and swamps.
Answer:
Chromosome 11 is made of over
⇒ 130 million base pairs.
Approximately ⇒ 2000 genes are found on chromosome 11
Answer:
Changing the allosteric site would definitely impact the sensitivity of the blocker, and we can not understand precisely how it is owing to our lack of awareness of the specific adjustments and the FX11 layout.
Explanation:
The move would most likely reduce affinity, and FX11 will no longer be as successful as inhibiting C. Growth of parvum. An inhibitor may reach an allosteric site since the site has some sizes and operational classes that precisely match the shape and operational categories of the inhibitor, which is how the association is obtained if the shape is modified and the inclination is affected.
Such chemicals can be used as human drugs because the mechanism we 're disrupting isn't that normal in human cells, we 're talking about lactic fermentation. C.parvum is a parasite that is present in the digestive tract, and these areas do not appear to experience aerobic glycolysis. The material that undergoes this process under other conditions is muscle tissue. It is possible that the absorbed drug can penetrate the bloodstream and touch other organs, and we would recommend that clinicians avoid exercise during this drug therapy.
